Accendra Health Inc ACCH
News
Accendra Health Reports Third Quarter 2026 Financial Results
Accendra Health Announces Extension of $150 Million Receivables Sale Program To 2029
Accendra Health Receives Continued Listing Standard Notice from NYSE Regarding Market Capitalization and Stockholders’ Equity; Intends to Submit Business Plan and Return to Compliance with NYSE Listing Standard
Accendra Health Announces Third Quarter 2026 Earnings Release Date and Conference Call
Accendra Health Receives Continued Listing Standard Notice from NYSE; Intends to Cure Deficiency and Return to Compliance with NYSE Listing Standard
Accendra Health Names Kenneth Gardner-Smith as President and Chief Executive Officer to Lead the Company’s Next Chapter of Growth
